Loading...

PE Streptavidin PE Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Phycoerythrin, SAv-PE
Ave. Rating
Submit a Review
Product Citations
publications
SAV_PE_082808.jpg
C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
  • SAV_PE_082808.jpg
    C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
405203 100 µg DKK333
Check Availability


Need larger quantities of this item?
Request Bulk Quote
405204 500 µg DKK1159
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Phycoerythrin (PE) is useful for detecting biotinylated antibodies. The excitation of PE by 488 nm laser light induces a light emission maximum of 575 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The streptavidin-PE solution should be stored undiluted between 2°C and 8°C, and protected from exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

This streptavidin product is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the PE conjugation. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Streptavidin-Phycoerythrin (PE) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE is 360 kD and Streptavidin alone is 52 kD.

Application References
  1. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245.
  2. Nishimoto KP,et al. 2008. J. Immunol. 181:4010.PubMed
  3. Niki T, et al. 2009. J. Biol. Chem. 284:32344. PubMed
  4. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  5. Scatizzi JC, et al. 2012. J. Immunol. 188:3307. PubMed
  6. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  7. Shibata T, et al. 2012. Int Immunol. 24:613. PubMed
  8. Baccala R, et al. 2012. J. Immunol. 189:5976. PubMed
  9. Grevers LC, et al. 2013. Ann Reheum Dis. 72:278. PubMed
  10. Woo SJ, et al. 2013. J Leukoc Biol. 93:363. PubMed
  11. Ashbaugh JJ, et al. 2013. J. Immunol. 190:4525. PubMed
  12. Reading JL, 2013. J. immunol. 190:4542. Pubmed.
  13. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  14. Gunaydin G, et al. 2014. Vaccine. 32:470. PubMed
  15. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  16. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  17. He X, et al. 2014. J Immunol. 193:1314. PubMed
  18. Wang W, et al. 2014. PNAS. 111:14466. PubMed
  19. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  20. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  21. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  22. Hua X, et al. 2015. PloS One. 10:128039. PubMed
Product Citations
  1. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  2. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  3. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  4. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  5. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  6. Campisi L, et al. 2022. Nature. 606:945. PubMed
  7. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  8. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  9. Cao Y, et al. 2023. Nature. 614:521. PubMed
  10. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  11. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  12. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  13. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  14. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  15. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Feng J, et al. 2022. Immunity. 55:405. PubMed
  18. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  19. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  20. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  21. Ke F, et al. 2023. Elife. 12:. PubMed
  22. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  23. Silva RP, et al. 2023. Elife. 12:. PubMed
  24. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  25. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  26. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  27. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  28. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  29. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  30. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  31. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  32. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  33. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  34. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  35. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  36. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  37. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  38. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  39. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  40. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  41. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  42. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  43. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  44. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  45. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  46. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  47. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  48. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  49. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  50. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  51. Biswas S, et al. 2021. Nature. 591:464. PubMed
  52. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  53. Gniffke EP, et al. 2020. medRxiv. . PubMed
  54. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  55. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  56. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  57. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  58. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  59. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  60. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  61. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  62. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  63. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  64. Cao Y, et al. 2022. Nature. :. PubMed
  65. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  66. Im S, et al. 2016. Nature. 537:417-421. PubMed
  67. Schanda N, et al. 2021. Cells. 10:. PubMed
  68. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  69. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  70. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  71. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  72. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  73. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  74. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  75. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  76. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  77. Cao Y, et al. 2022. Nature. 602:657. PubMed
  78. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  79. Köchl R, et al. 2020. Elife. 9:00. PubMed
  80. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  81. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  82. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  83. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  84. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  85. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  86. Weiß S, et al. 2020. medRxiv. . PubMed
  87. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  88. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  89. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  90. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  91. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  92. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  93. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  94. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  95. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  96. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  97. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  98. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  99. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  100. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  101. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  102. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  103. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  104. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  105. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  106. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  107. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  108. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  109. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  110. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  111. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  112. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  113. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  114. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  115. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  116. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  117. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  118. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  119. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  120. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  121. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  122. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  123. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  124. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  125. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  126. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  127. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  128. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  129. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  130. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  131. Dan JM, et al. 2021. Science. :371. PubMed
  132. He X, et al. 2014. J Immunol. 193:1314. PubMed
  133. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  134. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  135. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  136. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  137. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  138. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  139. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  140. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  141. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  142. Wells DK, et al. 2020. Cell. 183:818. PubMed
  143. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  144. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  145. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  146. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  147. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  148. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  149. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  150. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  151. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  152. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  153. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  154. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  155. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  156. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  157. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  158. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  159. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  160. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  161. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  162. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  163. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  164. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  165. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  166. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  167. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  168. Campisi L, et al. 2022. Nature. 606:945. PubMed
  169. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  170. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  171. Cao Y, et al. 2023. Nature. 614:521. PubMed
  172. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  173. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  174. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  175. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  176. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  177. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  178. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  179. Feng J, et al. 2022. Immunity. 55:405. PubMed
  180. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  181. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  182. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  183. Ke F, et al. 2023. Elife. 12:. PubMed
  184. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  185. Silva RP, et al. 2023. Elife. 12:. PubMed
  186. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  187. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  188. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  189. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  190. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  191. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  192. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  193. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  194. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  195. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  196. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  197. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  198. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  199. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  200. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  201. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  202. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  203. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  204. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  205. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  206. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  207. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  208. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  209. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  210. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  211. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  212. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  213. Biswas S, et al. 2021. Nature. 591:464. PubMed
  214. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  215. Gniffke EP, et al. 2020. medRxiv. . PubMed
  216. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  217. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  218. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  219. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  220. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  221. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  222. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  223. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  224. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  225. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  226. Cao Y, et al. 2022. Nature. :. PubMed
  227. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  228. Im S, et al. 2016. Nature. 537:417-421. PubMed
  229. Schanda N, et al. 2021. Cells. 10:. PubMed
  230. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  231. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  232. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  233. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  234. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  235. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  236. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  237. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  238. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  239. Cao Y, et al. 2022. Nature. 602:657. PubMed
  240. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  241. Köchl R, et al. 2020. Elife. 9:00. PubMed
  242. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  243. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  244. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  245. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  246. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  247. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  248. Weiß S, et al. 2020. medRxiv. . PubMed
  249. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  250. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  251. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  252. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  253. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  254. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  255. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  256. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  257. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  258. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  259. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  260. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  261. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  262. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  263. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  264. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  265. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  266. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  267. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  268. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  269. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  270. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  271. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  272. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  273. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  274. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  275. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  276. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  277. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  278. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  279. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  280. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  281. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  282. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  283. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  284. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  285. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  286. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  287. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  288. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  289. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  290. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  291. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  292. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  293. Dan JM, et al. 2021. Science. :371. PubMed
  294. He X, et al. 2014. J Immunol. 193:1314. PubMed
  295. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  296. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  297. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  298. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  299. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  300. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  301. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  302. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  303. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  304. Wells DK, et al. 2020. Cell. 183:818. PubMed
  305. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  306. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  307. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  308. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  309. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  310. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  311. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  312. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  313. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  314. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  315. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  316. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  317. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  318. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  319. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  320. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  321. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  322. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  323. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  324. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 6    Revision Date: 06/17/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Phycoerythrin, SAv-PE
Ave. Rating
Submit a Review
Product Citations
publications
SAV_PE_082808.jpg
C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
  • SAV_PE_082808.jpg
    C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
405203 100 µg DKK333
Check Availability


Need larger quantities of this item?
Request Bulk Quote
405204 500 µg DKK1159
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Phycoerythrin (PE) is useful for detecting biotinylated antibodies. The excitation of PE by 488 nm laser light induces a light emission maximum of 575 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The streptavidin-PE solution should be stored undiluted between 2°C and 8°C, and protected from exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

This streptavidin product is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the PE conjugation. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Streptavidin-Phycoerythrin (PE) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE is 360 kD and Streptavidin alone is 52 kD.

Application References
  1. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245.
  2. Nishimoto KP,et al. 2008. J. Immunol. 181:4010.PubMed
  3. Niki T, et al. 2009. J. Biol. Chem. 284:32344. PubMed
  4. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  5. Scatizzi JC, et al. 2012. J. Immunol. 188:3307. PubMed
  6. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  7. Shibata T, et al. 2012. Int Immunol. 24:613. PubMed
  8. Baccala R, et al. 2012. J. Immunol. 189:5976. PubMed
  9. Grevers LC, et al. 2013. Ann Reheum Dis. 72:278. PubMed
  10. Woo SJ, et al. 2013. J Leukoc Biol. 93:363. PubMed
  11. Ashbaugh JJ, et al. 2013. J. Immunol. 190:4525. PubMed
  12. Reading JL, 2013. J. immunol. 190:4542. Pubmed.
  13. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  14. Gunaydin G, et al. 2014. Vaccine. 32:470. PubMed
  15. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  16. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  17. He X, et al. 2014. J Immunol. 193:1314. PubMed
  18. Wang W, et al. 2014. PNAS. 111:14466. PubMed
  19. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  20. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  21. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  22. Hua X, et al. 2015. PloS One. 10:128039. PubMed
Product Citations
  1. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  2. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  3. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  4. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  5. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  6. Campisi L, et al. 2022. Nature. 606:945. PubMed
  7. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  8. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  9. Cao Y, et al. 2023. Nature. 614:521. PubMed
  10. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  11. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  12. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  13. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  14. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  15. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Feng J, et al. 2022. Immunity. 55:405. PubMed
  18. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  19. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  20. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  21. Ke F, et al. 2023. Elife. 12:. PubMed
  22. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  23. Silva RP, et al. 2023. Elife. 12:. PubMed
  24. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  25. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  26. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  27. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  28. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  29. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  30. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  31. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  32. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  33. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  34. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  35. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  36. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  37. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  38. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  39. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  40. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  41. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  42. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  43. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  44. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  45. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  46. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  47. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  48. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  49. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  50. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  51. Biswas S, et al. 2021. Nature. 591:464. PubMed
  52. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  53. Gniffke EP, et al. 2020. medRxiv. . PubMed
  54. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  55. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  56. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  57. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  58. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  59. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  60. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  61. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  62. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  63. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  64. Cao Y, et al. 2022. Nature. :. PubMed
  65. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  66. Im S, et al. 2016. Nature. 537:417-421. PubMed
  67. Schanda N, et al. 2021. Cells. 10:. PubMed
  68. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  69. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  70. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  71. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  72. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  73. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  74. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  75. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  76. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  77. Cao Y, et al. 2022. Nature. 602:657. PubMed
  78. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  79. Köchl R, et al. 2020. Elife. 9:00. PubMed
  80. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  81. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  82. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  83. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  84. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  85. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  86. Weiß S, et al. 2020. medRxiv. . PubMed
  87. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  88. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  89. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  90. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  91. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  92. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  93. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  94. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  95. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  96. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  97. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  98. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  99. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  100. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  101. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  102. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  103. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  104. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  105. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  106. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  107. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  108. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  109. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  110. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  111. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  112. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  113. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  114. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  115. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  116. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  117. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  118. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  119. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  120. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  121. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  122. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  123. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  124. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  125. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  126. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  127. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  128. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  129. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  130. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  131. Dan JM, et al. 2021. Science. :371. PubMed
  132. He X, et al. 2014. J Immunol. 193:1314. PubMed
  133. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  134. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  135. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  136. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  137. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  138. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  139. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  140. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  141. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  142. Wells DK, et al. 2020. Cell. 183:818. PubMed
  143. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  144. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  145. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  146. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  147. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  148. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  149. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  150. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  151. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  152. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  153. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  154. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  155. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  156. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  157. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  158. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  159. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  160. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  161. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  162. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  163. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  164. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  165. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  166. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  167. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  168. Campisi L, et al. 2022. Nature. 606:945. PubMed
  169. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  170. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  171. Cao Y, et al. 2023. Nature. 614:521. PubMed
  172. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  173. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  174. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  175. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  176. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  177. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  178. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  179. Feng J, et al. 2022. Immunity. 55:405. PubMed
  180. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  181. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  182. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  183. Ke F, et al. 2023. Elife. 12:. PubMed
  184. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  185. Silva RP, et al. 2023. Elife. 12:. PubMed
  186. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  187. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  188. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  189. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  190. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  191. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  192. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  193. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  194. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  195. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  196. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  197. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  198. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  199. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  200. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  201. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  202. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  203. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  204. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  205. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  206. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  207. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  208. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  209. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  210. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  211. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  212. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  213. Biswas S, et al. 2021. Nature. 591:464. PubMed
  214. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  215. Gniffke EP, et al. 2020. medRxiv. . PubMed
  216. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  217. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  218. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  219. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  220. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  221. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  222. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  223. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  224. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  225. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  226. Cao Y, et al. 2022. Nature. :. PubMed
  227. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  228. Im S, et al. 2016. Nature. 537:417-421. PubMed
  229. Schanda N, et al. 2021. Cells. 10:. PubMed
  230. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  231. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  232. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  233. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  234. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  235. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  236. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  237. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  238. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  239. Cao Y, et al. 2022. Nature. 602:657. PubMed
  240. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  241. Köchl R, et al. 2020. Elife. 9:00. PubMed
  242. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  243. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  244. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  245. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  246. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  247. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  248. Weiß S, et al. 2020. medRxiv. . PubMed
  249. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  250. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  251. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  252. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  253. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  254. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  255. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  256. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  257. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  258. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  259. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  260. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  261. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  262. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  263. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  264. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  265. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  266. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  267. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  268. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  269. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  270. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  271. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  272. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  273. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  274. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  275. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  276. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  277. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  278. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  279. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  280. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  281. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  282. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  283. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  284. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  285. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  286. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  287. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  288. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  289. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  290. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  291. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  292. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  293. Dan JM, et al. 2021. Science. :371. PubMed
  294. He X, et al. 2014. J Immunol. 193:1314. PubMed
  295. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  296. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  297. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  298. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  299. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  300. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  301. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  302. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  303. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  304. Wells DK, et al. 2020. Cell. 183:818. PubMed
  305. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  306. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  307. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  308. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  309. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  310. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  311. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  312. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  313. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  314. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  315. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  316. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  317. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  318. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  319. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  320. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  321. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  322. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  323. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  324. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 6    Revision Date: 06/17/2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account